Influence of blood glucose fluctuations on chemotherapy efficacy and safety in type 2 diabetes mellitus patients complicated with lung carcinoma

Figure 3 Correlation between mean amplitude of glycemic excursions and tumor markers in all patients. A: Correlation of mean amplitude of glycemic excursions (MAGE) with carbohydrate antigen 19-9 (CA19-9) level in all patients; B: Correlation of MAGE with CA125 level in all patients; C: Correlation of MAGE with carcinoembryonic antigen level in all patients; D: Correlation of MAGE with neuron-specific enolase level in all patients; E: Correlation of MAGE with cytokeratin 19 level in all patients. MAGE: Mean amplitude of glycemic excursions; CA19-9: Carbohydrate antigen 19-9; CEA: Carcinoembryonic antigen; NSE: Neuron-specific enolase; CYFRA21-1: Cytokeratin 19.